Articles by Anna Rogers, M.A.

September 26, 2023 — Jim Mullikin pioneered DNA sequencing technologies during the Human Genome Project and other major advances in genomics.

September 12, 2023 — NIH is establishing the Multi-Omics for Health and Disease Consortium, with approximately $11 million awarded in the consortium’s first year of funding. The new consortium aims to advance the generation and analysis of “multi-omic” data for human health research.

August 23, 2023 — The Telomere-to-Telomere (T2T) Consortium has generated the first truly complete sequence of a human Y chromosome - the final human chromosome to be fully sequenced.

July 11, 2023 — NHGRI appoints Elizabeth Tuck as the director of its NHGRI’s Education and Community Involvement Branch to oversee programs aiming to increase genomics literacy and education.

June 30, 2023 — NIH researchers researchers and collaborators have gained some key insights into the biological inner-workings of regrowing a body, the evolution of aging and a unique method to dispose of aging cells, by studying the genomes of a hermit crab (Hydractinia symbiolongicarpus).

February 21, 2023 — NIH researchers have identified a gene that makes yeast resistant to a lethal toxin.

February 16, 2023 — NIH researchers have developed and released an innovative software tool, called Verso, to assemble truly complete (i.e., gapless) genome sequences from a variety of species. The software makes the process of assembling complete genome sequences more affordable and accessible.

February 13, 2023 — NHGRI is honoring three individuals for their achievements in enhancing diversity, equity, inclusion and accessibility (DEIA) in the genomics workforce. These individuals are the first recipients of NHGRI’s Outstanding Award for Enhancing DEIA in the Genomics Workforce, which was launched this year and will be awarded annually.

February 10, 2023 — Researchers from NHGRI and the Undiagnosed Diseases Program (UDP) have discovered a new neurological condition characterized by issues with motor coordination and speech.

November 18, 2022 — David Bodine, founder of the Hematopoiesis Section and chief of the Genetics and Molecular Biology Branch, advanced the fields of gene therapy and hematology in his 38 years at the NIH. Now, he plans to continue his contributions to science as an emeritus and through training the next generation of scientists.